Results 11 to 20 of about 263,810 (291)
Summary: Background: Staging and treatment of human African trypanosomiasis caused by Trypanosoma brucei gambiense (g-HAT) required lumbar puncture to assess cerebrospinal fluid (CSF) and intravenous drugs that cross the blood–brain barrier for late ...
Victor Kande Betu Ku Mesu, DPH +23 more
doaj +1 more source
A four-step process for building sustainable access to diagnosis and treatment of Chagas disease
The vast majority of people with Chagas disease (CD) are undiagnosed and untreated. Improving access to diagnosis and treatment for CD involves confronting a wide range of barriers. This report discusses a collaborative approach to eliminate barriers and
Carolina Batista +4 more
doaj +1 more source
Objective Epilepsy is highly prevalent in onchocerciasis‐endemic African regions. Various types of epilepsy have been described in such regions based essentially on clinical characteristics.
Alexandre Morin +16 more
doaj +1 more source
Health systems analysis of eye care services in Zambia: evaluating progress towards VISION 2020 goals. [PDF]
BACKGROUND: VISION 2020 is a global initiative launched in 1999 to eliminate avoidable blindness by 2020. The objective of this study was to undertake a situation analysis of the Zambian eye health system and assess VISION 2020 process indicators on ...
Blanchet, K +7 more
core +3 more sources
Introduction To achieve the elimination of hepatitis C virus (HCV), substantial scale-up in access to testing and treatment is needed. This will require innovation and simplification of the care pathway, through decentralisation of testing and treatment ...
Jagpreet Chhatwal +26 more
doaj +1 more source
Tools for clinical examination have not fundamentally evolved since the invention of the stethoscope by René Laennec in the nineteenth century. However, three decades ago, the medical community started to consider repurposing ultrasound scanners to ...
Pascal Carpentier
doaj +1 more source
Study protocol for a cluster-randomized controlled trial of an NCD access to medicines initative: Evaluation of Novartis Access in Kenya [PDF]
INTRODUCTION: Novartis recently launched Novartis Access, an initiative to provide a basket of reduced price medicines for non-communicable diseases (NCDs) to be sold through the public and private nonprofit sectors in programme countries.
Ashigbie, Paul G. +5 more
core +1 more source
Piloting the Global Subsidy: The Impact of Subsidized Artemisinin-Based Combination Therapies Distributed Through Private Drug Shops in Rural Tanzania. [PDF]
WHO estimates that only 3% of fever patients use recommended artemisinin-based combination therapies (ACTs), partly reflecting their high prices in the retail sector from where many patients seek treatment.
Oliver J. Sabot +19 more
core +8 more sources
The drug and vaccine landscape for neglected diseases (2000–11): a systematic assessment
Background: In 1975–99, only 1·1% of new therapeutic products had been developed for neglected diseases. Since then, several public and private initiatives have attempted to mitigate this imbalance.
Dr. Belen Pedrique, MD +7 more
doaj +1 more source
In 2018 the Albert Hirschman Centre on Democracy in Geneva organized together with Europaeum and Alternautas, the workshop on “Democracy, Indigenous Rights and Ethno-Racial Mobilization: Latin America in Comparative Perspective.” This workshop was part ...
Diego Silva, Nancy Postero
doaj +1 more source

